Healthpeak Properties, Inc. (NYSE:DOC) Shares Purchased by Blue Trust Inc.

Blue Trust Inc. lifted its stake in Healthpeak Properties, Inc. (NYSE:DOC) by 27.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 14,006 shares of the real estate investment trust’s stock after purchasing an additional 2,990 shares during the quarter. Blue Trust Inc.’s holdings in Healthpeak Properties were worth $284,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. State Street Corp purchased a new position in Healthpeak Properties in the third quarter valued at $1,093,576,000. Geode Capital Management LLC purchased a new position in shares of Healthpeak Properties during the third quarter worth about $403,898,000. Charles Schwab Investment Management Inc. acquired a new position in Healthpeak Properties in the 3rd quarter valued at $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Healthpeak Properties in the 3rd quarter valued at approximately $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new stake in shares of Healthpeak Properties during the 3rd quarter worth $102,615,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Stock Performance

NYSE DOC opened at $20.66 on Monday. Healthpeak Properties, Inc. has a 1 year low of $16.01 and a 1 year high of $23.26. The stock has a market capitalization of $14.45 billion, a PE ratio of 43.96, a P/E/G ratio of 2.18 and a beta of 1.14. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The company’s 50 day simple moving average is $20.75 and its two-hundred day simple moving average is $21.55.

Analyst Upgrades and Downgrades

DOC has been the topic of several research reports. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and lifted their price target for the company from $20.00 to $28.00 in a research report on Monday, October 21st. Royal Bank of Canada boosted their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Robert W. Baird upped their price target on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Wells Fargo & Company reduced their price objective on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.15.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.